Definitive Healthcare eliminates second C-suite position amid executive overhaul
Photo | Matthew Wright
Kate Shamsuddin, chief operating officer at Definitive Healthcare of Framingham
In the latest addition in the extensive C-suite overhaul at Definitive Healthcare, the Framingham health data and technology firm has decided to eliminate its chief operating officer position.
Definitive Healthcare has agreed with current COO Kate Shamsuddin Jensen the position she held would be terminated, with Aug. 1 serving as her last day with the company, according to a Tuesday filing with the U.S. Securities and Exchange Commission.
Shamsuddin Jensen’s dismissal is part of an organizational restructuring of its executive leadership team, according to the release. As such, her departure constitutes a termination without cause. In 2019, WBJ named Shamsuddin Jensen as one of its Outstanding Women in Business.
The company’s decision to eliminate its COO role comes after Definitive Healthcare CEO and board member Robert Musslewhite resigned from his leading roles in January 2024. The company’s Founder Jason Krantz briefly resumed the CEO role on an interim basis before Kevin Coop was appointed as his replacement that May and assumed the role on June 24, 2024.
Before that, the company had hired Carrie Lazorchak as its chief revenue officer, effective Nov. 1, 2023. She resigned from the position, effective Aug. 2, and Definitive Healthcare no longer lists the position on its corporate leadership webpage.
On Nov. 7, in another executive leadership transition, the company announced it had reached a mutual agreement with CFO Richard Booth that he would step down from his role on June 1, in another termination without cause, according to the SEC filing.
On Feb. 4, the company’s board of directors named Casey Heller as Booth’s successor, with Heller beginning her Definitive Healthcare tenure on June 2, according to two separate SEC filings.
Definitive Healthcare was named as one of the country’s best public companies to work for by U.S. News & World Report. On a scale of one to five, the firm scored a five for work-life balance and comfort.
Definitive Healthcare’s stock was trading at $4.12 per share on the Nasdaq on Wednesday morning, up 6% since Tuesday morning.
Mica Kanner-Mascolo is a staff writer at Worcester Business Journal, who primarily covers the healthcare and diversity, equity, and inclusion industries.
WBJ Web Partners
Most Recent
Most Recent
0 Comments